Meyka Pro banner
Neovasc Inc.

Neovasc Inc. (NVCN) Stock Overview

Explore Neovasc Inc.’s financial performance, market position, analyst ratings, and future outlook.

NVCN●NASDAQ
HealthcareMedical - Devices
$30.03
$0.00(0.00%)
U.S. Market opens in 14h 26m

Neovasc Inc. (NVCN)

Meyka AI Score

Z

Key Financials

Market Cap82.9M
P/E Ratio-1.99
EPS (TTM)$-15.07
ROE-1.21%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$10.47

NVCN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Neovasc Inc. (NASDAQ: NVCN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Neovasc Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NVCN on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $10.47 for the NASDAQ listing.

Key metrics behind Neovasc Inc.'s NASDAQ-traded stock include a P/E ratio of -1.99 and a market capitalization of 82.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NVCN on the NASDAQ.

Price Performance (NASDAQ: NVCN)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.00%
3-Month Change
5.81%
6-Month Change
362.00%
Year-to-Date (YTD) Change
89.94%
1-Year Change
454.06%
3-Year Change
-53.98%
5-Year Change
-97.60%
All-Time (Max) Change
-99.52%

Contact Information

16042704344
13562 Maycrest Way, Richmond, BC, V6V 2J7

Company Facts

490 Employees
IPO DateMay 23, 2001
CountryCA

Frequently Asked Questions